Share on LinkedInShare on LinkedIn

ARTICLE · 02 JULY 2026

AI-Assisted Inventions In Brazil: Disclosure Risks For Biotech And Genus-Type Claims

Licks Attorneys
Licks Attorneys
Contributor
Licks Attorneys

Licks Attorneys

Licks Attorneys is one of Brazil’s most respected litigation law firms, having unparalleled...

View firm profile
Explore more from Licks Attorneys

Brazil's patent office is tightening disclosure requirements for AI-assisted inventions, particularly in biotechnology. While AI may assist the inventive process, inventorship remains human—but the real challenge lies in what must be disclosed when AI contributes to gene therapy and biotech patents.

BrazilIntellectual Property

Recent legislative and regulatory developments in Brazil suggest an emerging consensus: AI may assist the inventive process, but inventorship remains human. The difficult question is not who invented, but what must be disclosed when AI contributes to the invention.

On May 13, 2026, Brazilian Congress’ Committee on Science, Technology, and Innovation replaced the previous wording of Bill #3,936/2024 and recommended its approval with the proposed amendments. The legislative direction preserves inventorship for human actors and treats AI as a tool in the inventive process, rather than as an inventor.

This approach aligns, at least in broad terms, with the position currently adopted by the BRPTO. In August 2025, the BRPTO launched Public Consultation #3/2025 on draft Examination Guidelines for AI-related inventions. The proposal classifies such inventions into three categories: (i) AI models and techniques; (ii) AI-based inventions; and (iii) AI-assisted inventions. Regardless of the

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from